Showing results (31-40 of 418) with videos related to
Sort By:
Pageof 42
Trends in Cancer|July 30, 2023
Tumor-agnostic drug development in dMMR/MSI-H solid tumorsDeepak Bhamidipati, Vivek SubbiahTargeted Oncology|May 13, 2026
HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding PatientsVivek Subbiah, Martin DietrichJAMA Network Open|September 3, 2020
Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the USJustin T Moyers, Amie Patel, Wendy Shih, et al.Cancer Discovery|February 26, 2020
Advances in Targeting RET-Dependent CancersVivek Subbiah, Gilbert J CoteAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 9, 2023
Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for BRAF V600E-Positive Adult and Pediatric Solid TumorsMohamed A Gouda, Vivek SubbiahCancer Journal (Sudbury, Mass.)|November 16, 2022
Strategies for Mitigating Antibody-Drug Conjugate Related Adverse Events for Precision TherapyMohamed A Gouda, Vivek SubbiahTherapeutic Advances in Medical Oncology|June 26, 2023
Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancersMohamed A Gouda, Vivek SubbiahMed (New York, N.Y.)|November 12, 2022
Exportin(g) precision oncology beyond genomics with XPO1 inhibitionMohamed A Gouda, Vivek SubbiahCancer Discovery|December 4, 2019
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway InhibitionVivek Subbiah, Sumanta K PalCarcinogenesis|November 8, 2024
Redefining pancreatic cancer management with tumor-agnostic precision medicineNeha K Reddy, Vivek SubbiahPageof 42